Figure 4 | British Journal of Cancer

Figure 4

From: Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer

Figure 4

Linear regression plot illustrating the relationship between changes in tumour size according to RECIST (PD: increase of tumour size>20%; PR: regression of tumour size>30%; SD: not PD or PR; CR: no visible tumour) and the corresponding changes in circulating miRNA-126 (cir-miRNA-126) levels from baseline.

Back to article page